Integrated and Quantitative Proteomics of Human Tumors

Area of Science:

• Proteomics
• Biochemistry
• Oncology

Background:

• Quantitative proteomics is vital for analyzing protein expression in diseases like cancer.
• Advances in mass spectrometry enhance protein identification and quantification.
• Posttranslational modification (PTM) analysis, particularly phosphorylation, reveals biological mechanisms.

Purpose of the Study:

• To improve the accuracy of proteomic discoveries in human tumors.
• To address limitations of global protein quantification in biomarker identification.
• To present a comprehensive methodology for enhanced proteomic analysis.

Main Methods:

• Robust sample preparation using isobaric tag labeling.
• Enrichment of phosphopeptides using TiO2-based methods.
• Purification of glycopeptides via hydrazide-based techniques.
• Quantitative analysis and bioinformatics for data interpretation.

Main Results:

• The study details technical specificities for sample preparation and quantitative analysis.
• The methodology integrates global proteomics with PTM analysis for deeper insights.
• Successful application demonstrated in hepatocellular carcinoma, chondrosarcoma, and other tumor types.

Conclusions:

• Combining global proteomics with PTM analysis and bioinformatics is crucial for accurate biomarker discovery.
• The presented methods enhance the identification of robust biomarkers in human tumors.
• This integrated approach provides deeper biological understanding and aids therapeutic target identification.